Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity
Abstract
The in vivo formation of fibrillar proteinaceous deposits called amyloid is associated with more than 40 serious human diseases, collectively referred to as protein deposition diseases. In many cases the amyloid deposits are extracellular and are found associated with newly identified abundant extracellular chaperones (ECs). Evidence is presented suggesting an important regulatory role for ECs in amyloid formation and disposal in the body. A model is presented which proposes that, under normal conditions, ECs stabilize extracellular misfolded proteins by binding to them, and then guide them to specific cell receptors for uptake and subsequent degradation. Thus ECs and their receptors may be critical parts of a quality control system to protect the body against dangerously hydrophobic proteins/peptides. However, it also appears possible that in the presence of a high molar excess of misfolded protein, such as might occur during disease, the limited amounts of ECs available may actually exacebate pathology. Further advances in understanding of the mechanisms that control extracellularprotein folding are likely to identify new strategies for effective disease therapies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clusterin levels appear to influence amyloid-beta aggregation.
“CLU levels also appear to affect aggregation of Aβ (Oda, et al., 1995,Wilson, et al., 2008)”
From A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin (2016) · cites this paper as Wilson, et al., 2008
The citation lists haven’t been fetched yet
References 131 · Cited by 142
- Authors
- Wilson, M. R., Yerbury, J. J., & Poon, S.
- Affiliations
- University of Wollongong (AU)
- Corresponding author
- Wilson, Mark R
- Venue
- Molecular BioSystems
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-19
- Volume
- 4
- Issue
- 1
- Pages
- 42-52
- ISSN
- 1742-2051 (ISSN-L)
- 1742-206X
- OpenAlex
- W2125730116
- Cited by
- 142
- References
- 131
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 4 · 2016: 8 · 2015: 12 · 2014: 11 · 2013: 10 · 2012: 12
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular BioSystems (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Figshare (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- extracellular chaperones, amyloid fibril formation, amyloid toxicity, misfolded protein clearance, protein quality control, amyloidosis
- MeSH terms
- alpha-Macroglobulins, Amyloid, Animals, Extracellular Space, Haptoglobins, Humans, Models, Biological, Models, Molecular, Protein Processing, Post-Translational, Protein Folding, Molecular Chaperones, Clusterin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review